CEO, Marguron Pharmaceuticals, Inc.
Vijai is CEO of Marguron Pharmaceuticals, Inc. Previously he was Founder and CEO of Secure Transfusion Solutions, Inc., a company dedicated to increasing the safety and availability of apheresis blood components for use in clinical settings. Prior to STS, he spent nearly two decades as a life sciences institutional investor at private equity firm Arcline Investment Management and hedge fund Origin Capital Management. As a Partner at Arcline, Vijai led supply chain investments in the cell and gene therapy space. As Director of Research and Partner at Origin, Vijai managed healthcare dedicated portfolios on behalf of institutional investors. Early in his career, he led corporate finance and investor relations at Onyx Pharmaceuticals, an early gene therapy pioneer. Vijai graduated from the University of Pennsylvania with a Masters in Biotechnology and a BA in Economics and Molecular Biology. He is also a CFA charterholder and lives in Austin, Texas with his wife and three daughters.